Expert Opin Drug Saf. 2007 May;6(3):289-303.

Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology.

Source

Johns Hopkins University School of Medicine, McKusick Nathans Institute of Genetic Medicine, Baltimore, MD 21205, USA. georg@rhone.ch

Abstract

Methadone is used as the pharmacologic mainstay for substitution for illegal opiates and as analgesic for chronic or cancer-related pain. Given the benefits of methadone substitution for illicit opioids, the finding of an association between methadone and prolongation of cardiac depolarization (QT prolongation) and torsades de pointes is of great concern. QT prolongation can occur with many drugs and is a potentially lethal adverse drug reaction, necessitating risk monitoring and therapeutic alternatives in some patients. Recent studies suggest that QT prolongation with methadone is context dependent: occurrence is more frequent with high doses of methadone, concomitant administration of CYP3A4 inhibitors, hypokalemia, hepatic failure, administration of other QT prolonging drugs and pre-existing heart disease. The valued benefit of methadone substitution therapy on the one hand and the increased cardiovascular risk in particular situations on the other illustrate the difficulties in dealing with drug-induced QT prolongation in general.

PMID:: 17480178; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Methadone

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Molecular Biology Databases

METHADONE - HSDB

Supplemental Content

Save items

Related citations in PubMed

Torsades de pointes with methadone. [Prescrire Int. 2005]
Torsades de pointes with methadone.
. Prescrire Int. 2005 Apr; 14(76):61-2.
Review [Drug induced QT prolongation]. [Wien Klin Wochenschr. 2008]
Review [Drug induced QT prolongation].
Altmann D, Eggmann U, Ammann P. Wien Klin Wochenschr. 2008; 120(5-6):128-35.
Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes. [Pharmacotherapy. 2003]
Dose-related effects of methadone on QT prolongation in a series of patients with torsade de pointes.
Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS. Pharmacotherapy. 2003 Jun; 23(6):802-5.
QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system. [Pharmacoepidemiol Drug Saf. 2005]
QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.
Pearson EC, Woosley RL. Pharmacoepidemiol Drug Saf. 2005 Nov; 14(11):747-53.
Review Drugs that cause Torsades de pointes and increase the risk of sudden cardiac death. [Curr Cardiol Rep. 2004]
Review Drugs that cause Torsades de pointes and increase the risk of sudden cardiac death.
Wolbrette DL. Curr Cardiol Rep. 2004 Sep; 6(5):379-84.

See reviews... See all...

Cited by 2 PubMed Central articles

Torsades de pointes associated with methadone and voriconazole. [BMJ Case Rep. 2009]
Torsades de pointes associated with methadone and voriconazole.
Reinhold JA, Sanoski CA, Russo AM, Cooper JM, Spinler SA. BMJ Case Rep. 2009; 2009. Epub 2009 Dec 22.
Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine. [J Addict Dis. 2010]
Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine.
Unger A, Jung E, Winklbaur B, Fischer G. J Addict Dis. 2010 Apr; 29(2):217-30.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance
PubChem chemical substance records that cite the current articles. These references are taken from those provided on submitted PubChem chemical substance records.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Methadone-associated long QT syndrome: improving pharmacotherapy for dependence ...
Methadone-associated long QT syndrome: improving pharmacotherapy for dependence on illegal opioids and lessons learned for pharmacology.
Expert Opin Drug Saf. 2007 May ;6(3):289-303.

PubMed
Alzheimer's disease drug discovery from herbs: neuroprotectivity from beta-amylo...
Alzheimer's disease drug discovery from herbs: neuroprotectivity from beta-amyloid (1-42) insult.
J Altern Complement Med. 2007 Apr ;13(3):333-40.

PubMed
Chemotopic odorant coding in a mammalian olfactory system.
Chemotopic odorant coding in a mammalian olfactory system.
J Comp Neurol. 2007 Jul 1 ;503(1):1-34.

PubMed
Reversal of UDP-galactose 4-epimerase deficiency of human leukocytes in culture.
Reversal of UDP-galactose 4-epimerase deficiency of human leukocytes in culture.
Proc Natl Acad Sci U S A. 1975 Dec ;72(12):5026-30.

PubMed
A simple screening approach to reduce B*5701-associated abacavir hypersensitivit...
A simple screening approach to reduce B*5701-associated abacavir hypersensitivity on the basis of sequence variation in HIV reverse transcriptase.
Clin Infect Dis. 2007 Jun 1 ;44(11):1503-8. Epub 2007 Apr 18 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: